Cited by 1,733Renin-Angiotensin System StudiesEicosanoids and Hypertension PharmacologyCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Crackower, Michael A., Sarao, Renu, Oudit, Gavin Y., Yagil, Chana, Kozieradzki, Ivona, Scanga, Sam E., Oliveira-dos-Santos, Antonio J., da Costa, Joan, Zhang, Liyong, Pei, York, Scholey, James, Ferrario, Carlos M., Manoukian, Armen S., Chappell, Mark C., Backx, Peter H., Yagil, Yoram, Penninger, Josef M.·2002·Nature

DOI 10.1038/nature00786

Open this paper in CoChat — free account

Abstract

Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.

Integrity signals

Registry

Crossref · 10.1038/nature00786

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citation
Global Burden of Cardiovascular Diseases
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 3,014
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Essential Hypertension
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
The Berkeley Drosophila Genome Project Gene Disruption Project: Single P-Element Insertions Mutating 25% of Vital Drosophila Genes
Spradling, A. C., Stern, D., Beaton, A., Rehm, E. J., Laverty, T., Mozden, N., Misra, S., & Rubin, G. M. (1999) · Genetics · doi:10.1093/genetics/153.1.135 · Cited by 781

Flagged first, then by citations

Show all 44 references

1 of the 44 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 999

Interaction of ACE2 and integrin β1 in failing human heart
Lin, Q., Keller, R. S., Weaver, B. A., & Zisman, L. S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.05.005 · Cited by 39
Ca2+/calmodulin-activated phosphodiesterase 1A is highly expressed in rabbit cardiac sinoatrial nodal cells and regulates pacemaker function
Lukyanenko, Y., Younès, A., Lyashkov, A. E., Tarasov, K. V., Riordon, D. R., Lee, J., Sirenko, S., Kobrinsky, E., Ziman, B. D., Tarasova, Y. S., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.064 · Cited by 39
The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
Lumbers, E. R., Delforce, S. J., Pringle, K. G., & Smith, G. R. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00248 · Cited by 38
COVID-19 and Heart: From Clinical Features to Pharmacological Implications
Russo, V., Bottino, R., Carbone, A., Rago, A., Papa, A. A., Golino, P., & Nigro, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061944 · Cited by 39
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
Sifat, A. E., Nozohouri, S., Villalba, H., Vaidya, B., & Abbruscato, T. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000170 · Cited by 40
Amelioration of Cardiac Function and Activation of Anti-Inflammatory Vasoactive Peptides Expression in the Rat Myocardium by Low Level Laser Therapy
Manchini, M. T., Serra, A. J., Feliciano, R. D. S., Santana, E. T., Antônio, E. L., de Carvalho, P. D. T. C., Montemor, J., Crajoinas, R. O., Girardi, A. C. C., Tucci, P. J. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101270 · Cited by 39
Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure
Zheng, H., Liu, X., & Patel, K. P. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00330.2011 · Cited by 39
Structure of dimeric full-length human ACE2 in complex with B 0 AT1Preprint
Yan, R., Zhang, Y., Li, Y., Xia, L., & Zhou, Q. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.17.951848 · Cited by 39
Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
Ferrario, C. M. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3141 · Cited by 39
Self-citation
High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT2R-MasR axis in obese Zucker rats
Samuel, P., Ali, Q., Sabuhi, R., Wu, Y., & Hussain, T. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00097.2012 · Cited by 38
Candesartan Ameliorates Cardiac Dysfunction Observed in Angiotensin-Converting Enzyme 2-Deficient Mice
Nakamura, K., Koibuchi, N., Nishimatsu, H., Higashikuni, Y., Hirata, Y., Kugiyama, K., Nagai, R., & Sata, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.1953 · Cited by 38
Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes
Tikellis, C., Brown, R., Head, G. A., Cooper, M. E., & Thomas, M. C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00264.2013 · Cited by 39
New aspects of the renin–angiotensin system: angiotensin-converting enzyme 2 – a potential target for treatment of hypertension and diabetic nephropathy
BATLLE, D. C., Soler, M. J., & Wysocki, J. A. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f945c2 · Cited by 39
Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis
Xie, X. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000185 · Cited by 38
Recombinant Angiotensin-Converting Enzyme 2 Suppresses Pulmonary Vasoconstriction in Acute Hypoxia
Kleinsasser, A. T., Pircher, I., Treml, B., Schwienbacher, M., Schuster, M., Janzek, E., Loibner, H., Penninger, J. M., & Loeckinger, A. (2012) · Wilderness and Environmental Medicine · doi:10.1016/j.wem.2011.09.002 · Cited by 38
Self-citation
Angiotensin‐converting enzyme 2 as a novel target for gene therapy for hypertension
Katovich, M. J., Grobe, J. L., Huentelman, M. J., & Raizada, M. K. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2004.028522 · Cited by 38
ACE polymorphisms and COVID-19-related mortality in Europe
Bellone, M., & Calvisi, S. L. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01981-0 · Cited by 37
Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes
Parhizgar, P., Yazdankhah, N., Rzepka, A. M., Chung, K. Y. C., Ali, I., Fur, R. L. F., Russell, V. R., & Cheung, A. M. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.01.031 · Cited by 37
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Carvajal, J. J., García-Castillo, V., Cuellar, S. V., Campillay-Véliz, C. P., Salazar‐Ardiles, C., Avellaneda, A. M., Muñoz, C. A., Retamal-Díaz, A. R., Bueno, S. M., González, P. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363572 · Cited by 42
Chymase-dependent production of angiotensin II: an old enzyme in old hearts
Froogh, G., Pinto, J. T., Le, Y., Kandhi, S., Aleligne, Y., Huang, A., & Sun, D. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00534.2016 · Cited by 37
Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2
da Silva, J. S., Gabriel‐Costa, D., Wang, H., Ahmad, S., Sun, X., Varagić, J., Sudo, R. T., Ferrario, C. M., Italia, L. J. D., Zapata‐Sudo, G., et al. (2017) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320317722270 · Cited by 37
Self-citation
Focus on increased serum angiotensin-converting enzyme level: From granulomatous diseases to genetic mutations
Lopez‐Sublet, M., di Lanzacco, L. C., Danser, A. H. J., Lambert, M. J., Elourimi, G., & Persu, A. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.06.010 · Cited by 37
Targeting Crucial Host Factors of SARS-CoV-2
Tharappel, A. M., Samrat, S. K., Li, Z., & Li, H. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00456 · Cited by 36
Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
Khezri, M. R., Zolbanin, N. M., Ghasemnejad‐Berenji, M., & Jafari, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174191 · Cited by 40
Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
Higashikuni, Y., Liu, W., Obana, T., & Sata, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112081 · Cited by 38
Decreased Expression of Angiotensin-Converting Enzyme 2 in Pancreatic Ductal Adenocarcinoma Is Associated with Tumor Progression
Zhou, L., Zhang, R., Yao, W., Wang, J., Qian, A., Qiao, M.-M., Zhang, Y., & Yuan, Y. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.217.123 · Cited by 37
Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese
Huang, W., Yang, W., Wang, Y., Zhao, Q., Gu, D., & Chen, R. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002090 · Cited by 37
Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis
Wysocki, J. A., Ye, M., & BATLLE, D. C. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv054 · Cited by 37
High-intensity interval training has beneficial effects on cardiac remodeling through local renin-angiotensin system modulation in mice fed high-fat or high-fructose diets
Sá, G. D. O., Neves, V. D. S., Fraga, S. R. D. O., Souza‐Mello, V., & Barbosa‐da‐Silva, S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.09.012 · Cited by 38
Requirement of transcription factor NFAT in developing atrial myocardium
Schubert, W., Yang, X. Y., Yang, T. T. C., Factor, S. M., Lisanti, M. P., Molkentin, J. D., Rincón, M., & Chow, C.-W. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301058 · Cited by 37
The renin–angiotensin system in acute respiratory distress syndrome
Imai, Y., Kuba, K., & Penninger, J. M. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.06.012 · Cited by 37
Self-citation
The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease.
Chaoxin, J., Daili, S., Yan-xin, H., Ruwei, G., Chenlong, W., & Yaobin, T. (2013) · PubMed · Cited by 36
Epochs in the depressor/pressor balance of the renin–angiotensin system
Colafella, K. M. M., Hilliard, L. M., & Denton, K. M. (2016) · Clinical Science · doi:10.1042/cs20150939 · Cited by 36
Future drug discovery in renin-angiotensin-aldosterone system intervention
Tamargo, M., & Tamargo, J. L. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1335301 · Cited by 35
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study
Mangion, K., Morrow, A., Bagot, C. N., Bayes, H. K., Blyth, K. G., Church, C., Corcoran, D. S., Delles, C., Gillespie, L., Grieve, D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa209 · Cited by 37
Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases
Sharma, R. K., Li, J., Krishnan, S., Richards, E. M., Raizada, M. K., & Mohandas, R. (2021) · Clinical Science · doi:10.1042/cs20200482 · Cited by 36
Two ACEs and a heart
Bernstein, K. E. (2002) · Nature · doi:10.1038/417799a · Cited by 36
Tissue-Specific Pattern of Angiotensin-Converting Enzyme 2 Expression in Rat Pancreas
Fang, H.-J., & Yang, J. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800218 · Cited by 36
Cardiovascular Effects of Losartan and Its Relevant Clinical Application
Xu, F., Mao, C., Hu, Y., Rui, C., Xu, Z., & Zhang, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789178046 · Cited by 36
Self-citation
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)
Ahmad, S., & Ferrario, C. M. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1531848 · Cited by 36
Self-citation
Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019
Li, L., Zhou, Q., & Xu, J. (2020) · BioMed Research International · doi:10.1155/2020/7413673 · Cited by 35
Immunometabolic Status of COVID-19 Cancer Patients
Sica, A., Colombo, M. P., Trama, A., Horn, L., Garassino, M. C., & Torri, V. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2020 · Cited by 35
The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic
Dan, S., Pant, M., & Upadhyay, S. K. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00239-0 · Cited by 35
ACE2‐based decoy receptors for SARS coronavirus 2
Jing, W., & Procko, E. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26140 · Cited by 32
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension
Tsutamoto, T., Nishiyama, K., Yamaji, M., Kawahara, C., Fujii, M., Yamamoto, T., & Horie, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.192 · Cited by 35
The RAAS Goodfellas in Cardiovascular System
Caputo, I., Bertoldi, G., Driussi, G., Cacciapuoti, M., & Calò, L. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216873 · Cited by 36
ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus)
Chou, C.-F., Loh, C. B., Foo, Y. K., Shen, S., Fielding, B. C., Tan, T. H. P., Khan, S., Wang, Y., Lim, S. G., Hong, W., et al. (2006) · Gene · doi:10.1016/j.gene.2006.03.010 · Cited by 32
Circulating ACE2: a novel biomarker of cardiovascular risk
Ramchand, J., & Burrell, L. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32011-0 · Cited by 34
Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection
Festa, M., Sansone, C., Brunet, C., Crocetta, F., Paola, L. D., Lombardo, M., Bruno, A., Noonan, D. M., & Albini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218364 · Cited by 36
Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer
Couselo‐Seijas, M., Almengló, C., Agra-Bermejo, R. M., Fernández, Á. L., Álvarez, E., González‐Juanatey, J. R., & Eiras-Penas, S. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13463 · Cited by 34
Data-driven molecular design for discovery and synthesis of novel ligands: a case study on SARS-CoV-2
Born, J., Manica, M., Cadow, J., Markert, G., Mill, N. A., Filipavicius, M., Janakarajan, N., Cardinale, A., Laino, T., & Martínez, M. R. (2021) · Machine Learning Science and Technology · doi:10.1088/2632-2153/abe808 · Cited by 35
ACE2 Is Expressed in Immune Cells That Infiltrate the Placenta in Infection-Associated Preterm Birth
Lye, P., Dunk, C., Zhang, J., Wei, Y., Nakpu, J., Hamada, H., Império, G. E., Bloise, E., Matthews, S. G., & Lye, S. J. (2021) · Cells · doi:10.3390/cells10071724 · Cited by 36
Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies
Ho, H. T., Peischard, S., Strutz‐Seebohm, N., Klingel, K., & Seebohm, G. (2021) · Viruses · doi:10.3390/v13091880 · Cited by 36
Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats
Fernandes, T. M., Hashimoto, N. Y., & de Oliveira, E. M. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500088 · Cited by 34
The Renin-Angiotensin-Aldosterone System in Renal and Cardiovascular Disease and the Effects of its Pharmacological Blockade
Heras, M. M., Rodríguez, N. D. C., & Navarro‐González, J. F. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000171 · Cited by 35
Endothelin-A Receptor Blockade Prevents Left Ventricular Hypertrophy and Dysfunction in Salt-Sensitive Experimental Hypertension
Rothermund, L., Vetter, R., Dieterich, M., Kossmehl, P. P., Gögebakan, Ö., Yagil, C., Yagil, Y., & Kreutz, R. H. (2002) · Circulation · doi:10.1161/01.cir.0000038703.78148.54 · Cited by 34
Self-citation
Inflammation Alters Angiotensin Converting Enzymes (ACE and ACE-2) Balance in Rat Heart
Hanafy, S., Tavasoli, M., & Jamali, F. (2010) · Inflammation · doi:10.1007/s10753-010-9269-1 · Cited by 33
Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor
Cha, S. A., Park, B. M., Gao, S., & Kim, S. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.10.020 · Cited by 33
Utero-placental expression of angiotensin-(1–7) and ACE2 in the pregnant guinea-pig
Valdés, G., Corthorn, J. L., Bharadwaj, M. S., Joyner, J., Schneider, D., & Brosnihan, K. B. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-5 · Cited by 33
Angiotensin-converting enzyme 2
Tanonaka, K., & Marunouchi, T. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.147.120 · Cited by 33
Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review
Barati, F., Pouresmaieli, M., Ekrami, E., Asghari, S., Ziarani, F. R., & Mamoudifard, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00129-1 · Cited by 33
Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19
Medzikovic, L., Cunningham, C. M., Li, M., Amjedi, M., Hong, J. S., Ruffenach, G., & Eghbali, M. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.08.007 · Cited by 33
County-level longitudinal clustering of COVID-19 mortality to incidence ratio in the United States
Vahabi, N., ‎Salehi, M., Duarte, J. D., Mollalo, A., & Michailidis, G. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-82384-0 · Cited by 33
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
Srinivasan, K., Pandey, A. K., Livingston, A., & Venkatesh, S. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00060-1 · Cited by 36
Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease
Savedchuk, S., Raslan, R., Nystrom, S. E., & Sparks, M. A. (2022) · Circulation Research · doi:10.1161/circresaha.122.320873 · Cited by 34
Loss of Angiotensin-converting enzyme-related (ACER) peptidase disrupts night-time sleep in adult Drosophila melanogaster
Çarhan, A., Tang, K., Shirras, C., Shirras, A. D., & Isaac, R. E. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.049353 · Cited by 33
Effects of curcumin on angiotensin-converting enzyme gene expression, oxidative stress and anti-oxidant status in thioacetamide-induced hepatotoxicity
Fazal, Y., Fatima, S. N., Shahid, S. M., & Mahboob, T. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314545777 · Cited by 33
Structure, Evolutionary Conservation, and Functions of Angiotensin- and Endothelin-Converting Enzymes
Macours, N., Poels, J., Hens, K., Francis, C., & Huybrechts, R. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)39002-9 · Cited by 33
Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?
Elton, T. S., Sansom, S. E., & Martin, M. M. (2010) · International Journal of Hypertension · doi:10.4061/2010/281692 · Cited by 34
Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention
Yeung, K. S., Yamanaka, G. A., & Meanwell, N. A. (2006) · Medicinal Research Reviews · doi:10.1002/med.20055 · Cited by 31
The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2
Lai, Z. W., Lew, R. A., Yarski, M. A., Mu, F., Andrews, R. K., & Smith, A. I. (2009) · Endocrinology · doi:10.1210/en.2008-1274 · Cited by 32
Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
González, A. A., Cifuentes-Araneda, F., Ibaceta-González, C., González-Vergara, A., Zamora, L., Henriquez, R., Rosales, C. B., Navar, L. G., & Prieto, M. C. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00360.2015 · Cited by 33
Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure
Tanno, T., Tomita, H., Narita, I., Kinjo, T., Nishizaki, K., Ichikawa, H., Kimura, Y., Tanaka, Μ., Osanai, T., & Okumura, K. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000374 · Cited by 32
Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats
Ma, H., Kong, J., Wang, Y., Li, J., Hei, N.-H., Cao, X., Yang, J., Yan, W., Liang, W., Dai, H.-Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15595 · Cited by 32
Covid‐19, ACE2 and the kidney
Hardenberg, J.-H., & Luft, F. C. (2020) · Acta Physiologica · doi:10.1111/apha.13539 · Cited by 32
The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
Kim, S., Lee, S., Lee, S., Shim, S., Nguyen, T. T., Hwang, J., Kim, H., Choi, Y.-O., Hong, J., Bae, S., et al. (2020) · Immune Network · doi:10.4110/in.2020.20.e41 · Cited by 32
Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19
Cook, J. R., & Ausiello, J. C. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09663-z · Cited by 32
Characterization of the first angiotensin-converting like enzyme in bacteria: Ancestor ACE is already active
Rivière, G., Michaud, A., Corradi, H. R., Sturrock, E. D., Acharya, K. R., Cogez, V., Bohin, J., Vieau, D., & Corvol, P. L. (2007) · Gene · doi:10.1016/j.gene.2007.05.010 · Cited by 32
Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition
Inaba, S., Iwai, M., Furuno, M., Kan‐no, H., Senba, I., Okayama, H., Mogi, M., Higaki, J., & Horiuchi, M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834bbb4d · Cited by 32
Dissecting complex traits: the geneticists' ‘Around the world in 80 days’
Darvasi, A. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.05.003 · Cited by 32
Angiotensin converting enzyme 2 and the kidney
Ortiz-Melo, D. I., & Gurley, S. B. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000182 · Cited by 31
Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice
Roca-Ho, H., Palau, V., Gimeno, J., Pascual, J., Soler, M. J., & Riera, M. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0440-5 · Cited by 32
Dual deficiency of angiotensin‐converting enzyme‐2 and Mas receptor enhances angiotensin II‐induced hypertension and hypertensive nephropathy
Ni, J., Yang, F., Huang, X., Meng, J., Chen, J., Bäder, M., Penninger, J. M., Fung, E., Yu, X., & Lan, H. Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15914 · Cited by 31
Self-citation
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
Anand, S. P., Chen, Y., Prévost, J., Gasser, R., Beaudoin-Bussières, G., Abrams, C. F., Pazgier, M., & Finzi, A. (2020) · Viruses · doi:10.3390/v12101104 · Cited by 31
ACE2: At the crossroad of COVID-19 and lung cancer
Gottschalk, G., Knox, K. K., & Roy, A. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101077 · Cited by 31
Endomembrane remodeling in SARS-CoV-2 infection
Chen, D., Zhao, Y. G., & Zhang, H. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100031 · Cited by 33
Angiotensin-Converting Enzyme Inhibitors and Survival in Women and Men with Heart Failure
Keyhan, G., Chen, S., & Pilote, L. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.03.004 · Cited by 30
Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic
Heyman, S. N., Walther, T., & Abassi, Z. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061200 · Cited by 32
Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort
Palmer, B. R., Jarvis, M. D., Pilbrow, A. P., Ellis, K. L., Frampton, C. M., Skelton, L., Yandle, T. G., Doughty, R. N., WHALLEY, G. A., Ellis, C., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.013 · Cited by 30
Early imaging in heart failure: Exploring novel molecular targets
Shirani, J., Narula, J., Eckelman, W. C., Narula, N., & Dilsizian, V. (2007) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.12.318 · Cited by 30
Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation
Ciarka, A., van de Borne, P., & Pathak, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.9.1315 · Cited by 32
Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases
Parajuli, N., Ramprasath, T., Patel, V. B., Wang, W., Putko, B. N., Mori, J., & Oudit, G. Y. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0488 · Cited by 30
Self-citation
Cardiac ACE2/angiotensin 1–7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy
Diniz, G. P., Senger, N., Carneiro‐Ramos, M. S., Santos, R. A. S., & Barreto‐Chaves, M. L. M. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944715623228 · Cited by 30
Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice
Stegbauer, J., Thatcher, S. E., Yang, G., Bottermann, K., Rump, L. C., Daugherty, A., & Cassis, L. A. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.11.045 · Cited by 32
Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease
Abassi, Z. A., Skorecki, K. L., Hamo‐Giladi, D. B., Kruzel-Davila, E., & Heyman, S. N. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00548.2020 · Cited by 30
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Rajpoot, S., Ohishi, T., Kumar, A., Pan, Q., Banerjee, S., Zhang, K. Y. J., & Baig, M. S. (2021) · Drugs in R&D · doi:10.1007/s40268-021-00357-0 · Cited by 32
Diversity of Coronaviruses with Particular Attention to the Interspecies Transmission of SARS-CoV-2
Shehata, A. A., Attia, Y. A., Rahman, M. T., Basiouni, S., El-Seedi, H. R., Azhar, E. I., Khafaga, A. F., & Hafez, H. M. (2022) · Animals · doi:10.3390/ani12030378 · Cited by 30
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells
Giryes, S., Bragazzi, N. L., Bridgewood, C., Marco, G. D., & McGonagle, D. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00928-6 · Cited by 32
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders
Santiago, T. C., Parra, L., Nani, J. V. S., Fidalgo, T. M., Bradshaw, N. J., & Hayashi, M. A. F. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15806 · Cited by 30
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1–7)
Bernardi, S., Burns, W. C., Toffoli, B., Pickering, R. J., Sakoda, M., Tsorotes, D., Grixti, E., Velkoska, E., Burrell, L. M., Johnston, C. I., et al. (2012) · Clinical Science · doi:10.1042/cs20110403 · Cited by 30

Authors: Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C. M., Manoukian, A. S., Chappell, M. C., Backx, P. H., Yagil, Y., & Penninger, J. M.
Affiliations: University of Toronto (CA)
Institute of Molecular Biotechnology (AT)
University Health Network (CA)
Barzilai Medical Center (IL)
Atrium Health Wake Forest Baptist (US)
Corresponding author: Penninger, Josef M.
ORCID: Crackower, Michael A.
Oudit, Gavin Y.
Kozieradzki, Ivona
Zhang, Liyong
Pei, York
Scholey, James
Ferrario, Carlos M.
Chappell, Mark C.
Backx, Peter H.
Yagil, Yoram
Penninger, Josef M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2002-06
Volume: 417
Issue: 6891
Pages: 822-828
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature00786
OpenAlex: W2025672718
Cited by: 1,733
References: 44
Citations by year: 2026: 12 · 2025: 25 · 2024: 38 · 2023: 88 · 2022: 117 · 2021: 215 · 2020: 311 · 2019: 38 · 2018: 22 · 2017: 33 · 2016: 42 · 2015: 38 · 2014: 53 · 2013: 54 · 2012: 60
FWCI: 38.64
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amgen
German-Israeli Foundation for Scientific Research and Development
Canada Research Chairs
Israel Science Foundation
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: angiotensin-converting enzyme 2, ACE2, cardiac function, hypertension, quantitative trait loci, X chromosome, cardiac contractility, angiotensin II, hypoxia, Acer, cardiac morphogenesis, rat model, mouse knockout
MeSH terms: Angiotensin II, Animals, Hypoxia, Blood Pressure, Cloning, Molecular, Drosophila melanogaster, Female, Heart, Hypertension, Peptidyl-Dipeptidase A, Male, Metalloendopeptidases, Myocardial Contraction, Myocardium, X Chromosome, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Quantitative Trait, Heritable, Radiation Hybrid Mapping, Drosophila Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks